{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:26:45Z","timestamp":1769160405008,"version":"3.49.0"},"publisher-location":"Cham","reference-count":73,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319153377","type":"print"},{"value":"9783319153384","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-3-319-15338-4_42","type":"book-chapter","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T14:34:02Z","timestamp":1442586842000},"page":"941-959","source":"Crossref","is-referenced-by-count":3,"title":["Nanoparticle Functionalization for Brain Targeting Drug Delivery and Diagnostic"],"prefix":"10.1007","author":[{"given":"Maria Jo\u00e3o","family":"Gomes","sequence":"first","affiliation":[]},{"given":"B\u00e1rbara","family":"Mendes","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"issue":"3","key":"42_CR1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","volume":"36","author":"N. Joan Abbott","year":"2013","unstructured":"N.J. Abbott, Blood\u2013brain barrier structure and function and the challenges for CNS drug delivery. J. Inherit. Metab. Dis. 36, 1\u201313 (2013)","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"1","key":"42_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"N.J. Abbott, A.A. Patabendige, D.E. Dolman, S.R. Yusof, D.J. Begley, Structure and function of the blood\u2013brain barrier. Neurobiol. Dis. 37(1), 13\u201325 (2010)","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"42_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ejps.2010.05.003","volume":"40","author":"MI Alam","year":"2010","unstructured":"M.I. Alam, S. Beg, A. Samad, S. Baboota, K. Kohli, J. Ali, A. Ahuja, M. Akbar, Strategy for effective brain drug delivery. Eur. J. Pharm. Sci. 40(5), 385\u2013403 (2010)","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"42_CR4","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1124\/jpet.102.045856","volume":"304","author":"DD Allen","year":"2003","unstructured":"D.D. Allen, P.R. Lockman, K.E. Roder, L.P. Dwoskin, P.A. Crooks, Active transport of high-affinity choline and nicotine analogs into the central nervous system by the blood\u2013brain barrier choline transporter. J. Pharmacol. Exp. Ther. 304(3), 1268\u20131274 (2003)","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"42_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/10611869908996844","volume":"6","author":"L Araujo","year":"1999","unstructured":"L. Araujo, R. L\u00f6benberg, J. Kreuter, Influence of the surfactant concentration on the body distribution of nanoparticles. J. Drug Target. 6(5), 373\u2013385 (1999)","journal-title":"J. Drug Target."},{"issue":"7323","key":"42_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature09522","volume":"468","author":"A Armulik","year":"2010","unstructured":"A. Armulik, G. Genov\u00e9, M. M\u00e4e, M.H. Nisancioglu, E. Wallgard, C. Niaudet, L. He, J. Norlin, P. Lindblom, K. Strittmatter, Pericytes regulate the blood\u2013brain barrier. Nature 468(7323), 557\u2013561 (2010)","journal-title":"Nature"},{"issue":"12","key":"42_CR7","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.2174\/1381612043384844","volume":"10","author":"DJ Begley","year":"2004","unstructured":"D.J. Begley, ABC transporters and the blood\u2013brain barrier. Curr. Pharm. Des. 10(12), 1295\u20131312 (2004)","journal-title":"Curr. Pharm. Des."},{"key":"42_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1743-8977-7-3","volume":"7","author":"S Bhaskar","year":"2010","unstructured":"S. Bhaskar, F. Tian, T. Stoeger, W. Kreyling, J.M. de la Fuente, V. Grazu, P. Borm, G. Estrada, V. Ntziachristos, D. Razansky, Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood\u2013brain barrier: perspectives on tracking and neuroimaging. Part. Fibre Toxicol. 7, 3 (2010)","journal-title":"Part. Fibre Toxicol."},{"issue":"2","key":"42_CR9","first-page":"232","volume":"1816","author":"A Bolhassani","year":"2011","unstructured":"A. Bolhassani, Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer. Biochim. Biophys. Acta 1816(2), 232\u2013246 (2011)","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"42_CR10","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1124\/jpet.102.039669","volume":"303","author":"I Brigger","year":"2002","unstructured":"I. Brigger, J. Morizet, G. Aubert, H. Chacun, M.-J. Terrier-Lacombe, P. Couvreur, Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting. J. Pharmacol. Exp. Ther. 303(3), 928\u2013936 (2002)","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"42_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.brainresrev.2010.05.003","volume":"64","author":"FL Cardoso","year":"2010","unstructured":"F.L. Cardoso, D. Brites, M.A. Brito, Looking at the blood\u2013brain barrier: molecular anatomy and possible investigation approaches. Brain Res. Rev. 64(2), 328\u2013363 (2010)","journal-title":"Brain Res. Rev."},{"issue":"7","key":"42_CR12","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","volume":"64","author":"Y Chen","year":"2012","unstructured":"Y. Chen, L. Liu, Modern methods for delivery of drugs across the blood\u2013brain barrier. Adv. Drug Deliv. Rev. 64(7), 640\u2013665 (2012)","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"42_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2174\/1567201043334542","volume":"1","author":"Y Chen","year":"2004","unstructured":"Y. Chen, G. Dalwadi, H.A. Benson, Drug delivery across the blood\u2013brain barrier. Curr. Drug Deliv. 1(4), 361\u2013376 (2004)","journal-title":"Curr. Drug Deliv."},{"key":"42_CR14","first-page":"11","volume":"10","author":"YK Choi","year":"2008","unstructured":"Y.K. Choi, K.-W. Kim, Blood-neural barrier: its diversity and coordinated cell-to-cell communication. Genesis 10, 11 (2008)","journal-title":"Genesis"},{"key":"42_CR15","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/jps.2600710717","volume":"71","author":"P Couvreur","year":"1982","unstructured":"P. Couvreur, B. Kante, L. Grislain, M. Roland, P. Speiser, Toxicity of polyalkylcyanoacrylate nanoparticles II: doxorubicin-loaded nanoparticles. J. Pharm. Sci. 71, 790\u2013792 (1982)","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"42_CR16","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/j.1471-4159.2008.05720.x","volume":"107","author":"S Dauchy","year":"2008","unstructured":"S. Dauchy, F. Dutheil, R.J. Weaver, F. Chassoux, C. Daumas-Duport, P.O. Couraud, J.M. Scherrmann, I. De Waziers, X. Decl\u00e8ves, ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood\u2013brain barrier. J. Neurochem. 107(6), 1518\u20131528 (2008)","journal-title":"J. Neurochem."},{"key":"42_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.pharmtox.47.120505.105237","volume":"47","author":"A De Boer","year":"2007","unstructured":"A. De Boer, P. Gaillard, Drug targeting to the brain. Annu. Rev. Pharmacol. Toxicol. 47, 323\u2013355 (2007)","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"7","key":"42_CR18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-2275(20)31588-1","volume":"42","author":"M Dean","year":"2001","unstructured":"M. Dean, Y. Hamon, G. Chimini, The human ATP-binding cassette (ABC) transporter superfamily. J. Lipid Res. 42(7), 1007\u20131017 (2001)","journal-title":"J. Lipid Res."},{"issue":"4","key":"42_CR19","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1083\/jcb.138.4.877","volume":"138","author":"B Dehouck","year":"1997","unstructured":"B. Dehouck, L. Fenart, M.-P. Dehouck, A. Pierce, G. Torpier, R. Cecchelli, A new function for the LDL receptor: transcytosis of LDL across the blood\u2013brain barrier. J. Cell Biol. 138(4), 877\u2013889 (1997)","journal-title":"J. Cell Biol."},{"key":"42_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/0006-8993(87)90236-8","volume":"420","author":"KR Duffy","year":"1987","unstructured":"K.R. Duffy, W.M. Pardridge, Blood\u2013brain barrier transcytosis of insulin in developing rabbits. Brain Res. 420, 32\u201338 (1987)","journal-title":"Brain Res."},{"issue":"2","key":"42_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0026-0495(98)90007-5","volume":"37","author":"KR Duffy","year":"1988","unstructured":"K.R. Duffy, W.M. Pardridge, R.G. Rosenfeld, Human blood\u2013brain barrier insulin-like growth factor receptor. Metabolism 37(2), 136\u2013140 (1988)","journal-title":"Metabolism"},{"issue":"3 Suppl. 1","key":"42_CR22","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1161\/STROKEAHA.108.533117","volume":"40","author":"M Fisher","year":"2009","unstructured":"M. Fisher, Pericyte signaling in the neurovascular unit. Stroke 40(3 Suppl. 1), S13\u2013S15 (2009)","journal-title":"Stroke"},{"issue":"4","key":"42_CR23","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/nar\/gkl1126","volume":"35","author":"M Fisher","year":"2007","unstructured":"M. Fisher, M. Abramov, A. Van Aerschot, D. Xu, R.L. Juliano, P. Herdewijn, Inhibition of MDR1 expression with altritol-modified siRNAs. Nucleic Acids Res. 35(4), 1064\u20131074 (2007)","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"42_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","volume":"37","author":"R Gabathuler","year":"2010","unstructured":"R. Gabathuler, Approaches to transport therapeutic drugs across the blood\u2013brain barrier to treat brain diseases. Neurobiol. Dis. 37(1), 48\u201357 (2010)","journal-title":"Neurobiol. Dis."},{"key":"42_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ics.2005.02.022","volume":"1277","author":"PJ Gaillard","year":"2005","unstructured":"P.J. Gaillard, A. Brink, A.G. de Boer, Diphtheria toxin receptor-targeted brain drug delivery. Int. Congr. Ser. 1277, 185\u2013198 (2005)","journal-title":"Int. Congr. Ser."},{"issue":"3","key":"42_CR26","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jconrel.2012.06.022","volume":"164","author":"PJ Gaillard","year":"2012","unstructured":"P.J. Gaillard, C.C. Appeldoorn, J. Rip, R. Dorland, S.M. van der Pol, G. Kooij, H.E. de Vries, A. Reijerkerk, Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation. J. Control. Release 164(3), 364\u2013369 (2012)","journal-title":"J. Control. Release"},{"issue":"2","key":"42_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0939-6411(02)00081-4","volume":"54","author":"A Gessner","year":"2002","unstructured":"A. Gessner, A. Lieske, B.R. Paulke, R.H. Muller, Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. Eur. J. Pharm. Biopharm. 54(2), 165\u2013170 (2002)","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"42_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1166\/jbn.2007.015","volume":"3","author":"S Gill","year":"2007","unstructured":"S. Gill, R. L\u00f6benberg, T. Ku, S. Azarmi, W. Roa, E.J. Prenner, Nanoparticles: characteristics, mechanisms of action, and toxicity in pulmonary drug delivery \u2013 a review. J. Biomed. Nanotechnol. 3(2), 107\u2013119 (2007)","journal-title":"J. Biomed. Nanotechnol."},{"issue":"2","key":"42_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11481-007-9099-6","volume":"3","author":"JL Gilmore","year":"2008","unstructured":"J.L. Gilmore, X. Yi, L. Quan, A.V. Kabanov, Novel nanomaterials for clinical neuroscience. J. Neuroimmune Pharmacol. 3(2), 83\u201394 (2008)","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"3","key":"42_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/10611860500071292","volume":"13","author":"TM Goppert","year":"2005","unstructured":"T.M. Goppert, R.H. Muller, Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns. J. Drug Target. 13(3), 179\u2013187 (2005)","journal-title":"J. Drug Target."},{"key":"42_CR31","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1023\/A:1018983904537","volume":"16","author":"A Gulyaev","year":"1999","unstructured":"A. Gulyaev, S. Gelperina, I. Skidan, A. Antropov, G. Kivman, J. Kreuter, Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. Pharm. Res. 16, 1564\u20131569 (1999)","journal-title":"Pharm. Res."},{"issue":"5","key":"42_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1124\/mi.10.5.6","volume":"10","author":"A Hartz","year":"2010","unstructured":"A. Hartz, B. Bauer, Regulation of ABC transporters at the blood\u2013brain barrier: new targets for CNS therapy. Mol. Interv. 10(5), 293 (2010)","journal-title":"Mol. Interv."},{"issue":"3","key":"42_CR33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","volume":"10","author":"F Herv\u00e9","year":"2008","unstructured":"F. Herv\u00e9, N. Ghinea, J.-M. Scherrmann, CNS delivery via adsorptive transcytosis. AAPS J. 10(3), 455\u2013472 (2008)","journal-title":"AAPS J."},{"issue":"17","key":"42_CR34","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1007\/s00018-009-0053-z","volume":"66","author":"H Hillaireau","year":"2009","unstructured":"H. Hillaireau, P. Couvreur, Nanocarriers\u2019 entry into the cell: relevance to drug delivery. Cell. Mol. Life Sci. 66(17), 2873\u20132896 (2009)","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"42_CR35","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jconrel.2005.09.053","volume":"110","author":"GH Huynh","year":"2006","unstructured":"G.H. Huynh, D.F. Deen, F.C. Szoka Jr., Barriers to carrier mediated drug and gene delivery to brain tumors. J. Control. Release 110(2), 236\u2013259 (2006)","journal-title":"J. Control. Release"},{"key":"42_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0168-3659(01)00306-6","volume":"74","author":"RK Jain","year":"2001","unstructured":"R.K. Jain, Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J. Control. Release 74, 7\u201325 (2001)","journal-title":"J. Control. Release"},{"issue":"1","key":"42_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2217\/17435889.1.1.9","volume":"1","author":"K Jain","year":"2006","unstructured":"K. Jain, Role of nanotechnology in developing new therapies for diseases of the nervous system. Nanomedicine 1(1), 9\u201312 (2006)","journal-title":"Nanomedicine"},{"key":"42_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-983-9","volume-title":"The Handbook of Nanomedicine","author":"KK Jain","year":"2012","unstructured":"K.K. Jain, The Handbook of Nanomedicine (Springer, Dordrecht, 2012)"},{"issue":"8","key":"42_CR39","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/sj.bjp.0706279","volume":"145","author":"SW Jones","year":"2005","unstructured":"S.W. Jones, R. Christison, K. Bundell, C.J. Voyce, S.M. Brockbank, P. Newham, M.A. Lindsay, Characterisation of cell-penetrating peptide-mediated peptide delivery. Br. J. Pharmacol. 145(8), 1093\u20131102 (2005)","journal-title":"Br. J. Pharmacol."},{"issue":"23\u201324","key":"42_CR40","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.drudis.2008.09.005","volume":"13","author":"L Juillerat-Jeanneret","year":"2008","unstructured":"L. Juillerat-Jeanneret, The targeted delivery of cancer drugs across the blood\u2013brain barrier: chemical modifications of drugs or drug-nanoparticles? Drug Discov. Today 13(23\u201324), 1099\u20131106 (2008)","journal-title":"Drug Discov. Today"},{"issue":"2","key":"42_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jconrel.2007.12.018","volume":"127","author":"IP Kaur","year":"2008","unstructured":"I.P. Kaur, R. Bhandari, S. Bhandari, V. Kakkar, Potential of solid lipid nanoparticles in brain targeting. J. Control. Release 127(2), 97\u2013109 (2008)","journal-title":"J. Control. Release"},{"key":"42_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-60761-919-2_1","volume":"683","author":"M Lindgren","year":"2011","unstructured":"M. Lindgren, U. Langel, Classes and prediction of cell-penetrating peptides. Methods Mol. Biol. 683, 3\u201319 (2011)","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"42_CR43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"C.A. Lipinski, Lead-and drug-like compounds: the rule-of-five revolution. Drug. Discov. Today Technol. 1(4), 337\u2013341 (2004)","journal-title":"Drug. Discov. Today Technol."},{"issue":"1","key":"42_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"C.A. Lipinski, F. Lombardo, B.W. Dominy, P.J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23(1), 3\u201325 (1997)","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"42_CR45","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.biomaterials.2007.11.014","volume":"29","author":"L Liu","year":"2008","unstructured":"L. Liu, K. Guo, J. Lu, S.S. Venkatraman, D. Luo, K.C. Ng, E.-A. Ling, S. Moochhala, Y.-Y. Yang, Biologically active core\/shell nanoparticles self-assembled from cholesterol-terminated PEG\u2013TAT for drug delivery across the blood\u2013brain barrier. Biomaterials 29(10), 1509\u20131517 (2008)","journal-title":"Biomaterials"},{"issue":"1","key":"42_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1081\/DDC-120001481","volume":"28","author":"P Lockman","year":"2002","unstructured":"P. Lockman, R. Mumper, M. Khan, D. Allen, Nanoparticle technology for drug delivery across the blood\u2013brain barrier. Drug Dev. Ind. Pharm. 28(1), 1\u201313 (2002)","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"9\u201310","key":"42_CR47","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/10611860400015936","volume":"12","author":"PR Lockman","year":"2004","unstructured":"P.R. Lockman, J.M. Koziara, R.J. Mumper, D.D. Allen, Nanoparticle surface charges alter blood\u2013brain barrier integrity and permeability. J. Drug Target. 12(9\u201310), 635\u2013641 (2004)","journal-title":"J. Drug Target."},{"issue":"3","key":"42_CR48","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1567-5769(02)00271-0","volume":"3","author":"H Maeda","year":"2003","unstructured":"H. Maeda, J. Fang, T. Inutsuka, Y. Kitamoto, Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. Int. Immunopharmacol. 3(3), 319\u2013328 (2003)","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"42_CR49","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/med.20225","volume":"32","author":"S Majumdar","year":"2012","unstructured":"S. Majumdar, T.J. Siahaan, Peptide-mediated targeted drug delivery. Med. Res. Rev. 32(3), 637\u2013658 (2012)","journal-title":"Med. Res. Rev."},{"key":"42_CR50","first-page":"6387","volume":"46","author":"YM Matsumura","year":"1986","unstructured":"Y.M. Matsumura, H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46, 6387\u20136392 (1986)","journal-title":"Cancer Res."},{"issue":"3","key":"42_CR51","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1124\/jpet.105.097139","volume":"317","author":"K Michaelis","year":"2006","unstructured":"K. Michaelis, M.M. Hoffmann, S. Dreis, E. Herbert, R.N. Alyautdin, M. Michaelis, J. Kreuter, K. Langer, Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain. J. Pharmacol. Exp. Ther. 317(3), 1246\u20131253 (2006)","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"42_CR52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/A:1006948027674","volume":"20","author":"T Moos","year":"2000","unstructured":"T. Moos, E.H. Morgan, Transferrin and transferrin receptor function in brain barrier systems. Cell. Mol. Neurobiol. 20(1), 77\u201395 (2000)","journal-title":"Cell. Mol. Neurobiol."},{"issue":"2","key":"42_CR53","first-page":"129","volume":"2","author":"SK Murthy","year":"2007","unstructured":"S.K. Murthy, Nanoparticles in modern medicine: state of the art and future challenges. Int. J. Nanomedicine 2(2), 129\u2013141 (2007)","journal-title":"Int. J. Nanomedicine"},{"key":"42_CR54","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1517\/17425247.2013.762354","volume":"10","author":"K Nagpal","year":"2013","unstructured":"K. Nagpal, S.K. Singh, D.N. Mishra, Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB. Expert Opin. Drug Deliv. 10, 927\u2013955 (2013)","journal-title":"Expert Opin. Drug Deliv."},{"issue":"2","key":"42_CR55","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jconrel.2012.03.026","volume":"161","author":"A Nunes","year":"2012","unstructured":"A. Nunes, K.T. Al-Jamal, K. Kostarelos, Therapeutics, imaging and toxicity of nanomaterials in the central nervous system. J. Control. Release 161(2), 290\u2013306 (2012)","journal-title":"J. Control. Release"},{"issue":"4","key":"42_CR56","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0896-6273(02)01054-1","volume":"36","author":"WM Pardridge","year":"2002","unstructured":"W.M. Pardridge, Drug and gene delivery to the brain: the vascular route. Neuron 36(4), 555\u2013558 (2002)","journal-title":"Neuron"},{"issue":"2","key":"42_CR57","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1124\/mi.3.2.90","volume":"3","author":"WM Pardridge","year":"2003","unstructured":"W.M. Pardridge, Blood\u2013brain barrier drug targeting: the future of brain drug development. Mol. Interv. 3(2), 90 (2003)","journal-title":"Mol. Interv."},{"issue":"1","key":"42_CR58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"W.M. Pardridge, The blood\u2013brain barrier: bottleneck in brain drug development. NeuroRx 2(1), 3\u201314 (2005)","journal-title":"NeuroRx"},{"issue":"1\u20132","key":"42_CR59","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","volume":"12","author":"WM Pardridge","year":"2007","unstructured":"W.M. Pardridge, Blood\u2013brain barrier delivery. Drug Discov. Today 12(1\u20132), 54\u201361 (2007)","journal-title":"Drug Discov. Today"},{"issue":"9","key":"42_CR60","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/0026-0495(87)90099-0","volume":"36","author":"WM Pardridge","year":"1987","unstructured":"W.M. Pardridge, J. Eisenberg, J. Yang, Human blood\u2013brain barrier transferrin receptor. Metabolism 36(9), 892\u2013895 (1987)","journal-title":"Metabolism"},{"issue":"1","key":"42_CR61","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-3565(25)20567-5","volume":"259","author":"WM Pardridge","year":"1991","unstructured":"W.M. Pardridge, J.L. Buciak, P.M. Friden, Selective transport of an anti-transferrin receptor antibody through the blood\u2013brain barrier in vivo. J. Pharmacol. Exp. Ther. 259(1), 66\u201370 (1991)","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"42_CR62","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2174\/138955710791185082","volume":"10","author":"M Ribeiro","year":"2010","unstructured":"M. Ribeiro, M. Castanho, I. Serrano, In vitro blood\u2013brain barrier models-latest advances and therapeutic applications in a chronological perspective. Mini Rev. Med. Chem. 10(3), 263\u2013271 (2010)","journal-title":"Mini Rev. Med. Chem."},{"key":"42_CR63","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/brain\/awh191","volume":"127","author":"A Saleh","year":"2004","unstructured":"A. Saleh, M. Schroeter, C. Jonkmanns, H. Hartung, U. M\u00f6dder, S. Jander, In vivo MRI of brain inflammation in human ischaemic stroke. Brain 127, 1670\u20131677 (2004)","journal-title":"Brain"},{"issue":"1","key":"42_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2006.06.027","volume":"1109","author":"S Santaguida","year":"2006","unstructured":"S. Santaguida, D. Janigro, M. Hossain, E. Oby, E. Rapp, L. Cucullo, Side by side comparison between dynamic versus static models of blood? brain barrier in vitro: a permeability study. Brain Res. 1109(1), 1\u201313 (2006)","journal-title":"Brain Res."},{"key":"42_CR65","volume-title":"Nanomedicine: Technologies and Applications","author":"H Santos","year":"2012","unstructured":"H. Santos, L. Bimbo, J. das Neves, B. Sarmento, Nanoparticulate targeted drug delivery using peptides and proteins, in Nanomedicine: Technologies and Applications, ed. by T.J. Webster (Woodhead Publishing Limited, Cambridge, 2012)"},{"issue":"1","key":"42_CR66","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejpb.2010.11.002","volume":"77","author":"K Tahara","year":"2011","unstructured":"K. Tahara, Y. Miyazaki, Y. Kawashima, J. Kreuter, H. Yamamoto, Brain targeting with surface-modified poly(d, l-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration. Eur. J. Pharm. Biopharm. 77(1), 84\u201388 (2011). doi:10.1016\/j.ejpb.2010.11.002","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"8","key":"42_CR67","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.bbalip.2010.02.007","volume":"1801","author":"JE Vance","year":"2010","unstructured":"J.E. Vance, H. Hayashi, Formation and function of apolipoprotein E-containing lipoproteins in the nervous system. Biochim. Biophys. Acta 1801(8), 806\u2013818 (2010)","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"42_CR68","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/jcbfm.2009.192","volume":"30","author":"JS Weinstein","year":"2010","unstructured":"J.S. Weinstein, C.G. Varallyay, E. Dosa, S. Gahramanov, B. Hamilton, W.D. Rooney, L.L. Muldoon, E.A. Neuwelt, Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J. Cereb. Blood Flow Metab. 30(1), 15\u201335 (2010)","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"4","key":"42_CR69","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.bbamem.2008.10.022","volume":"1788","author":"N Weiss","year":"2009","unstructured":"N. Weiss, F. Miller, S. Cazaubon, P.-O. Couraud, The blood\u2013brain barrier in brain homeostasis and neurological diseases. Biochim. Biophys. Acta 1788(4), 842\u2013857 (2009)","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"42_CR70","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejpb.2008.03.009","volume":"70","author":"B Wilson","year":"2008","unstructured":"B. Wilson, M.K. Samanta, K. Santhi, K.P. Kumar, N. Paramakrishnan, B. Suresh, Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles. Eur. J. Pharm. Biopharm. 70(1), 75\u201384 (2008). doi:10.1016\/j.ejpb.2008.03.009","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5\u20136","key":"42_CR71","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.wneu.2011.02.016","volume":"75","author":"JL Winer","year":"2011","unstructured":"J.L. Winer, P.E. Kim, M. Law, C.Y. Liu, M.L. Apuzzo, Visualizing the future: enhancing neuroimaging with nanotechnology. World Neurosurg. 75(5\u20136), 626\u2013637 (2011)","journal-title":"World Neurosurg."},{"issue":"2","key":"42_CR72","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jconrel.2011.08.017","volume":"161","author":"S Wohlfart","year":"2012","unstructured":"S. Wohlfart, S. Gelperina, J. Kreuter, Transport of drugs across the blood\u2013brain barrier by nanoparticles. J. Control. Release 161(2), 264\u2013273 (2012)","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"42_CR73","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ijpharm.2010.10.005","volume":"402","author":"H Xin","year":"2010","unstructured":"H. Xin, L. Chen, J. Gu, X. Ren, Z. Wei, J. Luo, Y. Chen, X. Jiang, X. Sha, X. Fang, Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(varepsilon-caprolactone) nanoparticles: in vitro and in vivo evaluation. Int. J. Pharm. 402(1\u20132), 238\u2013247 (2010)","journal-title":"Int. J. Pharm."}],"container-title":["Handbook of Nanoparticles"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-15338-4_42","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T18:14:29Z","timestamp":1748628869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-15338-4_42"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319153377","9783319153384"],"references-count":73,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-15338-4_42","relation":{},"subject":[],"published":{"date-parts":[[2016]]}}}